Aspirin as a therapeutic agent in cardiovascular d... [Circulation. 1997]

Review Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions. [Curr Atheroscler Rep. 2007]
Review Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions.
Hennekens CH. Curr Atheroscler Rep. 2007 Nov; 9(5):409-16.
Review Aspirin in cardiovascular disease. [Tenn Med. 2001]
Review Aspirin in cardiovascular disease.
Sexton RC Jr. Tenn Med. 2001 Jun; 94(6):208-10.
Review Update on aspirin in the treatment and prevention of cardiovascular disease. [Am J Manag Care. 2002]
Review Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH. Am J Manag Care. 2002 Dec; 8(22 Suppl):S691-700.
Review [Aspirin and prevention of cardiovascular risk] [Rev Med Interne. 2000]
Review [Aspirin and prevention of cardiovascular risk]
Karila-Cohen D, Gabriel Steg P. Rev Med Interne. 2000 Mar; 21 Suppl 1:35s-40s.
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. [Heart. 2001]
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
Sanmuganathan PS, Ghahramani P, Jackson PR, Wallis EJ, Ramsay LE. Heart. 2001 Mar; 85(3):265-71.

Driving-Related Cognitive Performance in Older Adults with Pharmacologically Treated Cardiovascular Disease. [Clin Gerontol. 2010]
Driving-Related Cognitive Performance in Older Adults with Pharmacologically Treated Cardiovascular Disease.
Viamonte S, Vance D, Wadley V, Roenker D, Ball K. Clin Gerontol. 2010 Apr 1; 33(2):109-123.
Cyclooxygenase products and atherosclerosis. [Drug Discov Today Ther Strateg. 2008]
Cyclooxygenase products and atherosclerosis.
Linton MF, Fazio S. Drug Discov Today Ther Strateg. 2008; 5(1):25-36.
Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. [J Am Soc Nephrol. 2009]
Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.
Chan KE, Lazarus JM, Thadhani R, Hakim RM. J Am Soc Nephrol. 2009 Apr; 20(4):872-81. Epub 2009 Mar 18.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Aspirin as a therapeutic agent in cardiovascular disease: a statement for health...
Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
Circulation. 1997 Oct 21 ;96(8):2751-3.

PubMed
Risk factors for coronary artery disease in non-insulin dependent diabetes melli...
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
BMJ. 1998 Mar 14 ;316(7134):823-8.

PubMed
The autonomic control of heart rate and insulin resistance in young adults.
The autonomic control of heart rate and insulin resistance in young adults.
J Clin Endocrinol Metab. 1999 Apr ;84(4):1263-7.

PubMed
Related Citations for PubMed (Select 16321162) (114)
PubMed
Related Citations for PubMed (Select 18570678) (474)
PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed